Genetic modification of mammalian cells to confer resistance to CSF1R antagonists
DE202022003132U1Active Publication Date: 2025-03-27RGT UNIV OF CALIFORNIA
2 Cites 0 Cited by
Patent Information
- Application Number
- DE202022003132
- Authority / Receiving Office
- DE · DE
- Patent Type
- Utility models
- Current Assignee / Owner
- Priority Date
- 2021-08-25
- Filing Date
- 2022-04-01
- Publication Date
- 2025-03-27
- Estimated Expiration
- 2032-04-30
Abstract
Modified human cell comprising a modified CSF1R protein that exhibits resistance to a CSF1R antagonist, wherein the modified CSF1R protein includes a modified ATP-binding pocket capable of binding ATP.
Need to check novelty before this filing date? Find Prior Art